Haferlach, Claudia
MLL Münchner Leukämielabor GmbH,
Germany
2025 Rank: 126338
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2279 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 126338 | 121708 |
| Total Cites | 1851 | 2098 |
| H-index | 19 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 30 | 33 |
| Number of Single+First+Last Authored Papers | 106 | 106 |
| Total Cites to Single+First+Last Authored Papers | 230 | 251 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1288 | 1406 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.49 |
| Self-Citation Percentage |
11.77%
|
|
Haferlach, Claudia
MLL Münchner Leukämielabor GmbH,
Germany
2024 Rank: 101641
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1976 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 101641 | 99639 |
| Total Cites | 1820 | 2111 |
| H-index | 17 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 41 | 43 |
| Number of Single+First+Last Authored Papers | 100 | 100 |
| Total Cites to Single+First+Last Authored Papers | 288 | 314 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1233 | 1357 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.56 |
| Self-Citation Percentage |
13.78%
|
|
Haferlach, Claudia
MLL Münchner Leukämielabor GmbH,
Germany
2023 Rank: 100114
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2119 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100114 | 103238 |
| Total Cites | 1673 | 1939 |
| H-index | 19 | 20 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 58 | 61 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 240 | 262 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1186 | 1305 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.49 |
| Self-Citation Percentage |
13.72%
|
|
Haferlach, Claudia
MLL Münchner Leukämielabor GmbH,
Germany
2022 Rank: 81272
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1950 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81272 | 86417 |
| Total Cites | 1920 | 2167 |
| H-index | 19 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 60 | 62 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 256 | 271 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1264 | 1372 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.58 |
| Self-Citation Percentage |
11.40%
|
|
Haferlach, Claudia
MLL Münchner Leukämielabor GmbH,
Germany
2021 Rank: 79589
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1772 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79589 | 80799 |
| Total Cites | 2759 | 3100 |
| H-index | 24 | 26 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 107 | 114 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 387 | 409 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1857 | 2001 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.55 |
| Self-Citation Percentage |
11.00%
|
|
Haferlach, Claudia
MLL Münchner Leukämielabor GmbH,
Germany
2020 Rank: 72179
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1524 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72179 | 77218 |
| Total Cites | 1961 | 2228 |
| H-index | 22 | 23 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 88 | 99 |
| Number of Single+First+Last Authored Papers | 82 | 82 |
| Total Cites to Single+First+Last Authored Papers | 304 | 331 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1384 | 1504 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.48 |
| Self-Citation Percentage |
11.98%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.